TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) Director Laurence N. Charney sold 17,500 shares of the company’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $19.03, for a total value of $333,025.00. Following the completion of the sale, the director now owns 237,229 […]